Imugene agrees to link with Merck after share spike
MELBOURNE: Paul Hopper-chaired cancer fighter Imugene has inked a deal with Merck & Co. to
MELBOURNE: Paul Hopper-chaired cancer fighter Imugene has inked a deal with Merck & Co. to